Skip to main content
Pharmaceuticals & Healthcare Verified Business Profile

Beacon Pharmaceuticals PLC

Exchange Ticker: DSE: BEACONPHAR

Pioneering oncology drug manufacturer listed on the DSE, producing targeted cancer therapies, biologicals, and chronic antiviral treatments.

Headquarters
Beacon Business Bhaban, 9/A/2 Toyenbee Circular Road, Motijheel, Dhaka, Bangladesh
Primary Sector
Pharmaceuticals & Healthcare
Established
2001
Editorial Status
Verified Documented

Manufactured Products & Services

Targeted Oncology Therapeutics Lyophilized Cytotoxic Injectables Monoclonal Antibodies & Biosimilars Novel Antiviral Formulations

Sectors & Client Industries

Oncology Formulations Biosimilars & Biotech DSE Listed Healthcare

Corporate Overview

Beacon Pharmaceuticals PLC is Bangladesh’s first manufacturer of oncology drugs. Its specialized cytotoxic manufacturing facility in Bhaluka, Mymensingh, produces over 100 cancer therapies, significantly lowering treatment costs for domestic patients and exporting to emerging markets.

Sources, Data & References

In accordance with BD Market Insights Editorial Standards, all factual claims, market sizes, and corporate data cited in this publication are cross-referenced with official filings, regulatory bodies, and industry documentation.

  1. Dhaka Stock Exchange BEACONPHAR Listing — dsebd.org (Accessed: September 28, 2026)
  2. BAPI Oncology Manufacturing Archive — bapi-bd.com (Accessed: September 28, 2026)

Entity Verification Policy

BD Market Insights publishes verified corporate profiles derived from public regulatory filings, direct corporate statements, and established industry documentation. We do not accept paid compensation for profile placement or rankings.

Read our selection criteria →